Clinical outcomes for neoadjuvant immunochemotherapy or chemotherapy versus concurrent chemoradiotherapy in limited‐stage small‐cell lung cancer: A retrospective, multi‐center, real‐world study

Ejemplares similares

• Induction immunochemotherapy followed by definitive chemoradiotherapy for unresectable locally advanced non‐small cell lung cancer: a multi‐institutional retrospective cohort study
  por: Leilei Wu, et al.
  Publicado: (2024)
• Perioperative outcomes in patients who undergo neoadjuvant chemoradiotherapy versus chemotherapy versus up‐front surgery in patients with oesophageal cancer
  por: Nazim Bhimani, et al.
  Publicado: (2024)
• Overall survival according to time‐of‐day of immunochemotherapy for extensive‐stage small cell lung cancer
  por: Zhe Huang, et al.
  Publicado: (2025)
• Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non‐metastatic stage T4 nasopharyngeal carcinoma in IMRT era
  por: Yuming Zheng, et al.
  Publicado: (2024)
• Durvalumab combined with concurrent chemoradiotherapy in patients with limited‐stage small cell lung cancer: A prospective, single‐arm, phase 2 clinical trial
  por: Chunyang Song, et al.
  Publicado: (2026)